Compile Data Set for Download or QSAR
Report error Found 30 Enz. Inhib. hit(s) with all data for entry = 50012515
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119826(5-(6-Amino-purin-9-yl)-pentanoic acid hydroxyamide...)
Affinity DataIC50: 7.60E+3nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119832(4-(6-Amino-purin-9-yl)-N-hydroxy-butyramide | CHEM...)
Affinity DataIC50: 7.90E+3nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119844(2-{[2-(6-Amino-purin-9-yl)-ethyl]-methyl-amino}-N-...)
Affinity DataIC50: 1.53E+4nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119842(6-(6-Amino-purin-9-yl)-hexanoic acid hydroxyamide ...)
Affinity DataIC50: 3.54E+4nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119821(2-[3-(6-Amino-purin-9-yl)-propoxy]-N-hydroxy-aceta...)
Affinity DataIC50: 9.40E+4nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119829([3-(6-Amino-purin-9-yl)-propoxy]-acetic acid | CHE...)
Affinity DataIC50: 1.41E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119849({Acetyl-[2-(6-amino-purin-9-yl)-ethyl]-amino}-acet...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119848([3-(6-Amino-purin-9-yl)-propylamino]-acetic acid |...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119845({[2-(6-Amino-purin-9-yl)-ethyl]-tert-butoxycarbony...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119843({Acetyl-[2-(6-amino-purin-9-yl)-ethyl]-amino}-acet...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119837(2-[3-(6-Amino-purin-9-yl)-propylamino]-N-hydroxy-a...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119840(7-(6-Amino-purin-9-yl)-heptanoic acid ethyl ester ...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119838(N-[2-(6-Amino-purin-9-yl)-ethyl]-N-hydroxycarbamoy...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119839([2-(6-Amino-purin-9-yl)-ethylamino]-acetic acid | ...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119836({[2-(6-Amino-purin-9-yl)-ethyl]-methyl-amino}-acet...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119841(2-[2-(6-Amino-purin-9-yl)-ethylamino]-N-hydroxy-ac...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119833(7-(6-Amino-purin-9-yl)-heptanoic acid hydroxyamide...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119835({[3-(6-Amino-purin-9-yl)-propyl]-tert-butoxycarbon...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119834([3-(6-Amino-purin-9-yl)-propylamino]-acetic acid m...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119830([2-(6-Amino-purin-9-yl)-ethylamino]-acetic acid me...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119831(7-(6-Amino-purin-9-yl)-heptanoic acid | CHEMBL1049...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119828(3-(6-Amino-purin-9-yl)-N-hydroxy-propionamide | CH...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119825([3-(6-Amino-purin-9-yl)-propoxy]-acetic acid ethyl...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119827(5-(6-Amino-purin-9-yl)-pentanoic acid methyl ester...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119824([2-(6-Amino-purin-9-yl)-ethyl]-hydroxycarbamoylmet...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119822(6-(6-Amino-purin-9-yl)-hexanoic acid ethyl ester |...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119823(6-(6-Amino-purin-9-yl)-hexanoic acid | CHEMBL10302...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119820(5-(6-Amino-purin-9-yl)-pentanoic acid | CHEMBL1016...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119847([3-(6-Amino-purin-9-yl)-propyl]-hydroxycarbamoylme...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAdenylate cyclase type 5(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119846({[2-(6-Amino-purin-9-yl)-ethyl]-tert-butoxycarbony...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed